RxDoctor Payments Data

Jessica Davis, MD

Anatomic Pathology & Clinical Pathology · Lafayette, INNPI 1750607966

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $54,705 of the $68,459 with a category attached, or 79.9%. Bayer accounts for 89.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $25,592 and has fallen 99.8% since, to $45 in 2025. Among anatomic pathology & clinical pathology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$68,459in general payments, 2019–2025

Across 36 payments — averaging $1901.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$61K
  • Lilly USA, LLC$4K
  • Boehringer Ingelheim$2K
  • Siemens Medical Solutions USA, Inc.$116
  • Roche Diagnostics Corporation$45
  • Chiesi USA, Inc.$19

What the payments were for

  • Consulting fees$54,70580%
  • Travel & lodging$13,36620%
  • Food & beverage$3891%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$68,459 in reported general payments places this provider in the 95th percentile of 137 anatomic pathology & clinical pathology providers in Indiana.

See all anatomic pathology & clinical pathology providers in Indiana

Medicare billing

Part B allowed, 2024
$8,046
Medicare patients
82
Services billed
214

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Lafayette

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →